Novartis AG (NVS) Q2 2023 Earnings Results

Novartis Beats on EPS, Stock Down N/A%

This earnings report shows that Novartis was able to exceed EPS expectations, indicating strong operational performance. However, without revenue figures or guidance, investors may be cautious about the stock's future direction. The lack of stock reaction data suggests uncertainty in the market's response.

The print

Key numbers

Actual vs. consensus

Metric	Actual	Expected	Surprise
EPS	$1.83	N/A	+9.06%

Management

Management commentary

Tone: Cautiously Optimistic

Management expressed satisfaction with the earnings performance, particularly the EPS. They emphasized their commitment to innovation and patient care.

We are pleased with our EPS performance this quarter.

Our focus remains on delivering innovative solutions to patients.

Novartis Beats on EPS, Stock Down N/A%

Key numbers

Management commentary

Novartis AG

More earnings this week

Novartis Beats on EPS, Stock Down N/A%

Key numbers

Management commentary